CHRISTINE DOPP: Open Payments
NPI 1548268113 · BLOOMSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,498 in 135 payments from 13 companies in 2025. Trend: 2023 $2,194 · 2024 $2,385 · 2025 $2,498
Food & beverage: $2,396Education: $101
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 31 | $575 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $365 |
| Neurocrine BioSciences, Inc. | 19 | $309 |
| Otsuka America Pharmaceutical, Inc. | 17 | $297 |
| Janssen Pharmaceuticals, Inc | 14 | $271 |
| Vanda Pharmaceuticals Inc. | 8 | $174 |
| Axsome Therapeutics, Inc. | 5 | $133 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $96 |
| Lundbeck LLC | 5 | $88 |
| Alkermes, Inc. | 3 | $68 |
Products named: CAPLYTA, AUSTEDO XR, INGREZZA, REXULTI, INVEGA SUSTENNA, FANAPT, Auvelity, UZEDY.
Industry payments across PA — which companies pay providers there.
